Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21511219 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention (PCI).
Conditions: Coronary Artery Disease (CAD);   Acute Coronary Syndrome (ACS)
Interventions: Drug: prasugrel;   Drug: clopidogrel

Indicates status has not been verified in more than two years